The FDA has informed Perrigo that, effective immediately, the company has an acceptable regulatory status, such that any pending export license and ANDA applications from this facility will once again be eligible for review and approval.
Perrigo is a healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products.